54 Capital invests $42 million in Addis Pharmaceutical - MarketLine Financial Deals

54 Capital invests $42 million in Addis Pharmaceutical

54 Capital invests $42 million in Addis Pharmaceutical - MarketLine Financial Deals
54 Capital invests $42 million in Addis Pharmaceutical
Published Jan 06, 2016
2 pages — Published Jan 06, 2016
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

54 Capital, Ltd., a UK-based asset management firm, has invested $42 million in Addis Pharmaceutical Factory PLC

  
Source:
Document ID
MA163662_160108
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "54 Capital invests $42 million in Addis Pharmaceutical" Jan 06, 2016. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/54-Capital-invests-42-million-in-Addis-Pharmaceutical-2052-117091>
  
APA:
MarketLine Financial Deals. (2016). 54 Capital invests $42 million in Addis Pharmaceutical Jan 06, 2016. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/54-Capital-invests-42-million-in-Addis-Pharmaceutical-2052-117091>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.